MEDICINOVA, INC. Income (Loss) from Equity Method Investments
MEDICINOVA, INC. (MNOV) reported Income (Loss) from Equity Method Investments of $19.87 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-02-13.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2020-02-13
- MEDICINOVA, INC. income (loss) from equity method investments for the quarter ending 2018-12-31 was $0.00.
- MEDICINOVA, INC. income (loss) from equity method investments for the quarter ending 2018-09-30 was $0.00.
- MEDICINOVA, INC. income (loss) from equity method investments for the quarter ending 2017-12-31 was $0.00.
- MEDICINOVA, INC. income (loss) from equity method investments for the quarter ending 2017-09-30 was $0.00.
- MEDICINOVA, INC. income (loss) from equity method investments for fiscal 2018 was $19.87K.
- MEDICINOVA, INC. income (loss) from equity method investments for fiscal 2017 was -$1.67K.
- MEDICINOVA, INC. income (loss) from equity method investments for fiscal 2016 was -$32.14K.
- MEDICINOVA, INC. income (loss) from equity method investments for fiscal 2015 was -$34.32K, a 1001.47% decline from fiscal 2014.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month | Income (Loss) from Equity Method Investments 12 month as first filed |
|---|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $0.00 derived: sum of 2 quarters · filed 2020-02-13 | $19.87K 10-K · filed 2020-02-13 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-24 | $19.87K 10-Q · filed 2019-10-24 | |||
| 2018-06-30 | $19.87K 10-Q · filed 2019-07-25 | ||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $0.00 derived: sum of 2 quarters · filed 2019-02-13 | $689.00 derived: sum of 3 quarters · filed 2019-02-13 | -$1.67K 10-K · filed 2019-02-13 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $689.00 derived: sum of 2 quarters · filed 2018-10-25 | -$1.67K 10-Q · filed 2018-10-25 | -$14.89K derived: sum of 4 quarters · filed 2019-02-13 | |
| 2017-06-30 | $689.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-23 | -$1.67K 10-Q · filed 2018-07-23 | -$14.89K derived: sum of 3 quarters · filed 2019-02-13 | -$18.86K derived: sum of 4 quarters · filed 2019-02-13 | |
| 2017-03-31 | -$2.36K 10-Q · filed 2018-04-25 | -$15.58K derived: sum of 2 quarters · filed 2019-02-13 | -$19.55K derived: sum of 3 quarters · filed 2019-02-13 | -$34.49K derived: sum of 4 quarters · filed 2019-02-13 | |
| 2016-12-31 | -$13.22K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | -$17.18K derived: sum of 2 quarters · filed 2019-02-13 | -$32.13K derived: sum of 3 quarters · filed 2019-02-13 | -$32.14K 10-K · filed 2019-02-13 | |
| 2016-09-30 | -$3.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-23 | -$18.91K derived: sum of 2 quarters · filed 2017-10-23 | -$18.92K 10-Q · filed 2017-10-23 | -$28.87K derived: sum of 4 quarters · filed 2018-02-13 | |
| 2016-06-30 | -$14.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | -$14.95K 10-Q · filed 2017-07-26 | -$24.90K derived: sum of 3 quarters · filed 2018-02-13 | -$44.17K derived: sum of 4 quarters · filed 2018-02-13 | |
| 2016-03-31 | -$13.00 10-Q · filed 2017-04-26 | -$9.96K derived: sum of 2 quarters · filed 2018-02-13 | -$29.23K derived: sum of 3 quarters · filed 2018-02-13 | -$33.27K derived: sum of 4 quarters · filed 2018-02-13 | |
| 2015-12-31 | -$9.95K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | -$29.22K derived: sum of 2 quarters · filed 2018-02-13 | -$33.26K derived: sum of 3 quarters · filed 2018-02-13 | -$34.32K 10-K · filed 2018-02-13 | $34.32K 10-K · filed 2016-02-25 |
| 2015-09-30 | -$19.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-25 | -$23.31K derived: sum of 2 quarters · filed 2016-10-25 | -$24.37K 10-Q · filed 2016-10-25 | -$29.91K derived: sum of 4 quarters · filed 2017-02-14 | |
| 2015-06-30 | -$4.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-26 | -$5.10K 10-Q · filed 2016-07-26 | -$10.64K derived: sum of 3 quarters · filed 2017-02-14 | -$3.25K derived: sum of 4 quarters · filed 2017-02-14 | |
| 2015-03-31 | -$1.06K 10-Q · filed 2016-04-27 | -$6.60K derived: sum of 2 quarters · filed 2017-02-14 | $790.00 derived: sum of 3 quarters · filed 2017-02-14 | $4.44K derived: sum of 4 quarters · filed 2017-02-14 | |
| 2014-12-31 | -$5.54K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $1.85K derived: sum of 2 quarters · filed 2017-02-14 | $5.50K derived: sum of 3 quarters · filed 2017-02-14 | $3.81K 10-K · filed 2017-02-14 | |
| 2014-09-30 | $7.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $11.04K derived: sum of 2 quarters · filed 2015-10-29 | $9.35K 10-Q · filed 2015-10-29 | ||
| 2014-06-30 | $3.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $1.96K 10-Q · filed 2015-07-30 | |||
| 2014-03-31 | -$1.69K 10-Q · filed 2015-05-11 | ||||
| 2013-12-31 | $13.78K 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |